
Cstone Submits Clinical Trial Application In Australia For CS5001 (ROR1 ADC) In Combination With First-Line Standard-Of-...
(MENAFN- PR Newswire) Phase Ib trial to evaluate CS5001 in combination with R-CHOP as a first-line treatment for diffuse large B-cell lymphoma (DLBCL), aiming to reshape the standard-of-care landscape. CS5001 is also being investigated globally in a multi- …